Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB1200984	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	Supplementary Application	2012-09-06	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2014-01-10	view
JYHB2001674	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	Supplementary Application	2020-09-03	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Filed	2020-09-15	view
JYHB1900465	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	Supplementary Application	2019-04-30	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Certificate Issued	2019-07-15	view
JYHB1100651	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	Supplementary Application	2011-09-07	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2012-07-05	view
JYHB1500842	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	Supplementary Application	2015-06-26			Certificate Issued	2017-03-21	view
J0401178	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	License Renew	2004-06-30	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Certificate Issued	2005-01-06	view
JYHZ2100579	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	License Renew	2021-07-30					view
JYHB1500349	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	Supplementary Application	2015-03-26			Certificate Issued	2015-06-11	view
A20020011	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	New Drug Application	2002-09-18	澳大利亚福尔丁有限公司北京代表处		In Approval		view
JYHB2100201	注射用甲磺酸去铁胺	deferoxamine mesilate	Lyophilized	Chemical Drugs	Supplementary Application	2021-03-20	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	In Review	2021-03-19	view
H20010097	去铁胺甲磺酸盐注射剂	deferoxamine mesilate	Lyophilized	Chemical Drugs	Import Drug Application	2001-04-17	香港诺华制药有限公司北京代表处		Approval Completed-Pending Certificated	2002-01-31	view